102
Participants
Start Date
December 31, 2013
Primary Completion Date
June 30, 2017
Study Completion Date
July 26, 2019
LVRC System
New York Presbyterian Columbia University Medical Center, New York
Emphysema COPD Research Center, University of Pittsburgh, Pittsburgh
Temple, Philadelphia
Duke University Medical Center, Durham
University of Florida, Gainesville
University of Alabama Lung Health Center, Birmingham
The Cleveland Clinic, Cleveland
University of Michigan Health System, Ann Arbor
CHU de Reims - Hopital Maison Blanche, Reims
University of Wisconsin School of Medicine & Public Health, Madison
Mayo Clinic, Rochester
Northwestern University, Chicago
Illinois Lung and Critical Care Institute, Peoria
Pulmonary, Critical Care & Sleep Medicine Consultants,PCCS/St. Luke's Episcopal Hospital, Houston
Cedars Sinai Medical Center, Los Angeles
El Camino Hospital/Palo Alto Medical Foundation, Mountain View
Franciscan Research Center, Tacoma
Yale University School of Medicine - Yale New Haven Hospital, New Haven
Beth Israel Deaconess Medical Center, Boston
Medical University of South Carolina, Charleston
University of Texas Health Sciences Center at San Antonio, San Antonio
Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ), Québec
Centre Hospitalier Universitaire de Nice, Nice
University Medical Center Groningen, Groningen
Royal Brompton Hospital & Chelsea Westminster, London
Lead Sponsor
Collaborators (1)
PneumRx, Inc.
INDUSTRY
Boston Scientific Corporation
INDUSTRY